Diagnostic Radiopharmaceutical Market 2027 By Imaging Modality, Application and Geography | The Insight Partners

Diagnostic Radiopharmaceutical Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Imaging Modality (Tc-99, Tl-201, Ga-67, I-123, F-18, Rb-82, Others); Application (Cardiology, Neurology, Thyroid, Others) and Geography

Report Code: TIPRE00015276 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

MARKET DYNAMICS

The diagnostic radiopharmaceutical market is driving due to the factors such as increasing prevalence of chronic diseases and improvement of healthcare institutions with safety measures. In addition, development and launch of new products in the developing nations of the world are likely to offer growth opportunities for market players.

MARKET SCOPE

The "Diagnostic Radiopharmaceutical Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diagnostic radiopharmaceutical market with detailed market segmentation by imaging modality and application. The diagnostic radiopharmaceutical market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diagnostic radiopharmaceutical market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The diagnostic radiopharmaceutical market is segmented on the basis of imaging modality and application. Based on imaging modality, the market is segmented as Tc-99, Tl-201, Ga-67, I-123, F-18, Rb-82, and others. On the basis of application, the market is segmented into cardiology, neurology, thyroid, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diagnostic radiopharmaceutical market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diagnostic radiopharmaceutical market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting diagnostic radiopharmaceutical market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the diagnostic radiopharmaceutical market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the diagnostic radiopharmaceutical market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diagnostic radiopharmaceutical market are anticipated to have lucrative growth opportunities in the future with the rising demand for diagnostic radiopharmaceutical in the global market. Below mentioned is the list of few companies engaged in the diagnostic radiopharmaceutical market.

The report also includes the profiles of key players in diagnostic radiopharmaceutical market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Bayer AG
  •  General Electric
  •  Cardinal Health, Inc.
  •  Nordion Inc.
  •  Siemens Healthineers
  •  Bracco Imaging
  •  Guerbet Group
  •  Curium
  •  NTP Radioisotopes
  •  Lanthus Holdings, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diagnostic Radiopharmaceutical Market - By Imaging Modality
1.3.2 Diagnostic Radiopharmaceutical Market - By Application
1.3.3 Diagnostic Radiopharmaceutical Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - GLOBAL MARKET ANALYSIS
6.1. DIAGNOSTIC RADIOPHARMACEUTICAL - GLOBAL MARKET OVERVIEW
6.2. DIAGNOSTIC RADIOPHARMACEUTICAL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2027 - IMAGING MODALITY
7.1. OVERVIEW
7.2. IMAGING MODALITY MARKET FORECASTS AND ANALYSIS
7.3. TC-99
7.3.1. Overview
7.3.2. Tc-99 Market Forecast and Analysis
7.4. TL-201
7.4.1. Overview
7.4.2. Tl-201 Market Forecast and Analysis
7.5. GA-67
7.5.1. Overview
7.5.2. Ga-67 Market Forecast and Analysis
7.6. I-123
7.6.1. Overview
7.6.2. I-123 Market Forecast and Analysis
7.7. F-18
7.7.1. Overview
7.7.2. F-18 Market Forecast and Analysis
7.8. RB-82
7.8.1. Overview
7.8.2. Rb-82 Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOLOGY
8.3.1. Overview
8.3.2. Cardiology Market Forecast and Analysis
8.4. NEUROLOGY
8.4.1. Overview
8.4.2. Neurology Market Forecast and Analysis
8.5. THYROID
8.5.1. Overview
8.5.2. Thyroid Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diagnostic Radiopharmaceutical Market Overview
9.1.2 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.1.3 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.1.4 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.1.5 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diagnostic Radiopharmaceutical Market
9.1.5.1.1 United States Diagnostic Radiopharmaceutical Market by Imaging Modality
9.1.5.1.2 United States Diagnostic Radiopharmaceutical Market by Application
9.1.5.2 Canada Diagnostic Radiopharmaceutical Market
9.1.5.2.1 Canada Diagnostic Radiopharmaceutical Market by Imaging Modality
9.1.5.2.2 Canada Diagnostic Radiopharmaceutical Market by Application
9.1.5.3 Mexico Diagnostic Radiopharmaceutical Market
9.1.5.3.1 Mexico Diagnostic Radiopharmaceutical Market by Imaging Modality
9.1.5.3.2 Mexico Diagnostic Radiopharmaceutical Market by Application
9.2. EUROPE
9.2.1 Europe Diagnostic Radiopharmaceutical Market Overview
9.2.2 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.2.3 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.2.4 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.2.5 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diagnostic Radiopharmaceutical Market
9.2.5.1.1 Germany Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.1.2 Germany Diagnostic Radiopharmaceutical Market by Application
9.2.5.2 France Diagnostic Radiopharmaceutical Market
9.2.5.2.1 France Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.2.2 France Diagnostic Radiopharmaceutical Market by Application
9.2.5.3 Italy Diagnostic Radiopharmaceutical Market
9.2.5.3.1 Italy Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.3.2 Italy Diagnostic Radiopharmaceutical Market by Application
9.2.5.4 Spain Diagnostic Radiopharmaceutical Market
9.2.5.4.1 Spain Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.4.2 Spain Diagnostic Radiopharmaceutical Market by Application
9.2.5.5 United Kingdom Diagnostic Radiopharmaceutical Market
9.2.5.5.1 United Kingdom Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.5.2 United Kingdom Diagnostic Radiopharmaceutical Market by Application
9.2.5.6 Rest of Europe Diagnostic Radiopharmaceutical Market
9.2.5.6.1 Rest of Europe Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.6.2 Rest of Europe Diagnostic Radiopharmaceutical Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diagnostic Radiopharmaceutical Market Overview
9.3.2 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.3.3 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.3.4 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diagnostic Radiopharmaceutical Market
9.3.5.1.1 Australia Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.1.2 Australia Diagnostic Radiopharmaceutical Market by Application
9.3.5.2 China Diagnostic Radiopharmaceutical Market
9.3.5.2.1 China Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.2.2 China Diagnostic Radiopharmaceutical Market by Application
9.3.5.3 India Diagnostic Radiopharmaceutical Market
9.3.5.3.1 India Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.3.2 India Diagnostic Radiopharmaceutical Market by Application
9.3.5.4 Japan Diagnostic Radiopharmaceutical Market
9.3.5.4.1 Japan Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.4.2 Japan Diagnostic Radiopharmaceutical Market by Application
9.3.5.5 South Korea Diagnostic Radiopharmaceutical Market
9.3.5.5.1 South Korea Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.5.2 South Korea Diagnostic Radiopharmaceutical Market by Application
9.3.5.6 Rest of Asia-Pacific Diagnostic Radiopharmaceutical Market
9.3.5.6.1 Rest of Asia-Pacific Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.6.2 Rest of Asia-Pacific Diagnostic Radiopharmaceutical Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diagnostic Radiopharmaceutical Market Overview
9.4.2 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.4.3 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.4.4 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diagnostic Radiopharmaceutical Market
9.4.5.1.1 South Africa Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.1.2 South Africa Diagnostic Radiopharmaceutical Market by Application
9.4.5.2 Saudi Arabia Diagnostic Radiopharmaceutical Market
9.4.5.2.1 Saudi Arabia Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.2.2 Saudi Arabia Diagnostic Radiopharmaceutical Market by Application
9.4.5.3 U.A.E Diagnostic Radiopharmaceutical Market
9.4.5.3.1 U.A.E Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.3.2 U.A.E Diagnostic Radiopharmaceutical Market by Application
9.4.5.4 Rest of Middle East and Africa Diagnostic Radiopharmaceutical Market
9.4.5.4.1 Rest of Middle East and Africa Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.4.2 Rest of Middle East and Africa Diagnostic Radiopharmaceutical Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diagnostic Radiopharmaceutical Market Overview
9.5.2 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.5.3 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.5.4 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.5.5 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diagnostic Radiopharmaceutical Market
9.5.5.1.1 Brazil Diagnostic Radiopharmaceutical Market by Imaging Modality
9.5.5.1.2 Brazil Diagnostic Radiopharmaceutical Market by Application
9.5.5.2 Argentina Diagnostic Radiopharmaceutical Market
9.5.5.2.1 Argentina Diagnostic Radiopharmaceutical Market by Imaging Modality
9.5.5.2.2 Argentina Diagnostic Radiopharmaceutical Market by Application
9.5.5.3 Rest of South and Central America Diagnostic Radiopharmaceutical Market
9.5.5.3.1 Rest of South and Central America Diagnostic Radiopharmaceutical Market by Imaging Modality
9.5.5.3.2 Rest of South and Central America Diagnostic Radiopharmaceutical Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DIAGNOSTIC RADIOPHARMACEUTICAL MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET, KEY COMPANY PROFILES
12.1. BAYER AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENERAL ELECTRIC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CARDINAL HEALTH, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NORDION INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SIEMENS HEALTHINEERS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRACCO IMAGING
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GUERBET GROUP
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CURIUM
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NTP RADIOISOTOPES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LANTHUS HOLDINGS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. General Electric
3. Cardinal Health, Inc.
4. Nordion Inc.
5. Siemens Healthineers
6. Bracco Imaging
7. Guerbet Group
8. Curium
9. NTP Radioisotopes
10. Lanthus Holdings, Inc.
TIPRE00015276
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking